Furthermore, extensive information on the precise signaling mechanisms and biological functions of each IL-17 member would pave the way for therapeutic interventions that selectively target specific IL-17 members for the treatment of IPF in humans. The gene discussed is IL17A; the disease is idiopathic pulmonary fibrosis.